缩泉益肾方对高糖诱导的HK-2细胞炎症因子影响的研究
Study on the Effect of Suoquan Yishen Formula on HK-2 Cell Inflammatory Factors Induced by High Sugar
DOI: 10.12677/TCM.2023.126201, PDF,   
作者: 王 珏, 谢毅强*:贵州中医药大学中医学院,贵州 贵阳;肖 曼:海南医学院生物技术学院,海南 海口
关键词: 糖尿病肾病缩泉益肾方炎症因子Diabetic Nephropathy Suoquan Yishen Formula Inflammatory Cytokines
摘要: 目的:观察缩泉益肾方对高糖(HG)诱导的HK-2细胞炎症因子的影响。方法:将HK-2细胞分成N组、HG组、5% SQYSF + HG组、10% SQYSF + HG组、20% SQYSF + HG组、Cana + HG组。经过细胞干预24 h后,使用CCK8法检测细胞存活比率,流逝细胞仪检测细胞凋亡比率,ELISA法检测细胞中TNF-α、IL-1β及IL-6炎症因子水平。使用GraphPad Prism 9.5对实验数据进行统计处理。结果:与N组相比,HG组细胞存活率明显降低、细胞凋亡率和炎性因子浓度显著增加(P < 0.05);且HG组与5% SQYSF + HG组(简称SL组)、10% SQYSF + HG组(简称SM组)、20% SQYSF + HG组(简称SH组)及Cana + HG组(简称Cana组)相比,差异具有统计学意义(P < 0.05)。与HG组比较,Cana组、SL组、SM组、SH组HK-2细胞存活率明显升高(P < 0.05)。对于TNF-α、IL-6、IL-1β炎症因子水平的影响,HG组与SL组、SM组、SH组及Cana组差异明显(P < 0.05)。结论:缩泉益肾方可降低HG诱导下HK-2细胞炎症因子水平。
Abstract: Objective: To observe the effect of Suoquan Yishen Formula on HK-2 cell inflammatory factors induced by high glucose (HG). Methods: HK-2 cells were divided into N group, HG group, 5% SQYSF + HG group, 10% SQYSF + HG group, 20% SQYSF + HG group and Cana + HG group. After 24 h of cell intervention, cell survival ratio was detected by CCK8 assay, cell apoptosis ratio was detected by elaptometry, and levels of TNF-α, IL-1β and IL-6 inflammatory factors were detected by ELISA. Statistical processing of experimental data was performed using GraphPad Prism 9.5. Results: Compared with N group, the survival rate of HG group was significantly decreased, the apoptosis rate and inflammatory factor concentration were significantly increased (P < 0.05). The differences between HG group and 5% SQYSF + HG group (SL group), 10% SQYSF + HG group (SM group), 20% SQYSF + HG group (SH group) and Cana + HG group (Cana group) were statistically significant (P < 0.05). Compared with HG group, the survival rate of HK-2 cells in Cana group, SL group, SM group and SH group was significantly increased (P < 0.05). There were significant differences between HG group and SL group, SM group, SH group and Cana group on the levels of TNF-α, IL-6 and IL-1β (P < 0.05). Conclusion: Suoquan Yishen Formula can reduce the level of HK-2 cell inflammatory factors induced by HG.
文章引用:王珏, 肖曼, 谢毅强. 缩泉益肾方对高糖诱导的HK-2细胞炎症因子影响的研究[J]. 中医学, 2023, 12(6): 1343-1350. https://doi.org/10.12677/TCM.2023.126201

参考文献

[1] García-García, P.M., Getino-Melián, M.A., Dominguez-Pimentel, V. and Navarro-González, J.F. (2014) Inflammation in Diabetic Kidney Disease. World Journal of Diabetes, 5, 431-443. [Google Scholar] [CrossRef] [PubMed]
[2] Donate-Correa, J., Martín-Nuñez, E., Muros-de-Fuentes, M., Mo-ra-Fernández, C. and Navarro-González, J.F. (2015) Inflammatory Cytokines in Diabetic Nephropathy. Journal of Diabetes Research, 2015, Article ID: 948417. [Google Scholar] [CrossRef] [PubMed]
[3] Rayego-Mateos, S., Morgado-Pascual, J.L., Opazo-Ríos, L., et al. (2020) Pathogenic Pathways and Therapeutic Approaches Targeting Inflammation in Diabetic Nephropathy. International Journal of Molecular Sciences, 21, Article No. 3798. [Google Scholar] [CrossRef] [PubMed]
[4] Navarro-González, J. and Mora-Fernández, C. (2008) The Role of Inflammatory Cytokines in Diabetic Nephropathy. Journal of the American Society of Nephrology, 19, 433-442. [Google Scholar] [CrossRef
[5] Navarro-González, J., Mora-Fernández, C., de Fuentes, M. and García-Pérez, J. (2011) Inflammatory Molecules and Pathways in the Pathogenesis of Diabetic Nephropathyy. Nature Reviews Nephrology, 7, 327-340. [Google Scholar] [CrossRef] [PubMed]
[6] Milas, O., Gadalean, F., Vlad, A., et al. (2020) Pro-Inflammatory Cytokines Are Associated with Podocyte Damage and Proximal Tubular Dysfunction in the Early Stage of Diabetic Kidney Disease in Type 2 Diabetes Mellitus Patients. Journal of Diabetes and Its Complications, 34, Article ID: 107479. [Google Scholar] [CrossRef] [PubMed]
[7] L,i Y., Hu, Q., Li, C., et al. (2019) PTEN-Induced Partial Epithelial-Mesenchymal Transition Drives Diabetic Kidney Disease. Journal of Clinical Investigation, 129, 1129-1151. [Google Scholar] [CrossRef
[8] Das, N.A., Carpenter, A.J., Belenchia, A., et al. (2020) Empagliflozin Reduces High Glucose-Induced Oxidative Stress and miR-21-Dependent TRAF3IP2 Induction and RECK Suppression, and Inhibits Human Renal Proximal Tubular Epithelial Cell Migration and Epithelial-to-Mesenchymal Transition. Cellular Signalling, 68, Article ID: 109506. [Google Scholar] [CrossRef] [PubMed]
[9] Ruster, C. and Wolf, G. (2008) The Role of Chemokines and Chemokine Receptors in Diabetic Nephropathy. Frontiers in Bioscience, 13, 944-955. [Google Scholar] [CrossRef] [PubMed]
[10] 张效丽, 周吉, 阴永辉. 芪归药对治疗糖尿病肾病疗效及对Nrf2通路的影响[J]. 山东中医杂志, 2020, 39(9): 944-949.
[11] Kong, C., Chen, D.F., Song, Z.H., et al. (2018) Exploration of Treating Diabetic Nephropathy with Astragalus and Angelica. Liaoning Journal of Traditional Chinese Medicine, 45, 267-269.
[12] 谢毅强, 尹德辉, 黄凌, 朱叶, 刘嫱. 一种用于治疗糖尿病肾病的中药组合物、中药制剂及其制备方法[P]. 中国专利, CN105878894A, 2016-08-24.
[13] 尹德辉, 朱叶, 倪雅丽, 姚宇剑, 林丹, 谢毅强. 缩泉益肾方治疗2型糖尿病肾病的临床疗效[J]. 中国老年学杂志, 2019, 39(9): 2091-2092.
[14] Zhang, J., Jiang, T., Liang, X., et al. (2019) LncRNA MALAT1 Mediated High Glucose-Induced K-2 Cell Epithelial-to-Mesenchymal Transition and Injury. Journal of Physiology and Biochemistry, 75, 443-452. [Google Scholar] [CrossRef] [PubMed]
[15] Zhang, J., Zhang, Q., Lou, Y., et al. (2018) Hypoxia-Inducible Factor-1α/Interleukin-1β Signaling Enhances Hepatoma Epithelial-Mesenchymal Transition through Macrophages in a Hypoxic-Inflammatory Microenvironment. Hepatology, 67, 1872-1889. [Google Scholar] [CrossRef] [PubMed]
[16] 张铭晖. 糖尿病肾病患者血清脂联素、脂蛋白A和白介素6水平变化及意义[J]. 河北医药, 2019, 41(17): 2642-2645.
[17] 张翠平. 血清OPG、TNF-α、IL-6水平与糖尿病肾病的关系[J]. 检验医学与临床, 2022, 19(2): 189-192.
[18] Tang, S.C.W. and Yiu, W.H. (2020) Innate Immunity in Diabetic Kidney Disease. Nature Reviews Nephrology, 16, 206-222. [Google Scholar] [CrossRef] [PubMed]
[19] Wellen, K.E. and Hotamisligil, G.S. (2005) Inflammation, Stress, and Diabetes. Journal of Clinical Investigation, 115, 1111-1119. [Google Scholar] [CrossRef
[20] Matoba, K., Takeda, Y., Nagai, Y., Kawanami, D., Utsunomiya, K. and Nishimura, R. (2019) Unraveling the Role of Inflammation in the Pathogenesis of Diabetic Kidney Disease. International Journal of Molecular Sciences, 20, Article No. 3393. [Google Scholar] [CrossRef] [PubMed]
[21] Pérez-Morales, R.E., Del Pino, M.D., Valdivielso, J.M., Ortiz, A., Mora-Fernández, C. and Navarro-González, J.F. (2019) Inflammation in Diabetic Kidney Disease. Nephron, 143, 12-16. [Google Scholar] [CrossRef] [PubMed]
[22] Panchapakesan, U., Pegg, K., Gross, S., et al. (2013) Effects of SGLT2 Inhibition in Human Kidney Proximal Tubular Cells—Renoprotection in Diabetic Nephropathy? PLOS ONE, 8, e54442. [Google Scholar] [CrossRef] [PubMed]
[23] Zhu, Y., Cui, H., Xia, Y. and Gan, H. (2016) RIPK3-Mediated Necroptosis and Apoptosis Contributes to Renal Tubular Cell Progressive Loss and Chronic Kidney Disease Progression in Rats. PLOS ONE, 11, e0156729. [Google Scholar] [CrossRef] [PubMed]
[24] Lv, L., Zhang, J., Tian, F., Li, X., Li, D. and Yu, X. (2019) Arbutin Protects HK-2 Cells against High Glucose-Induced Apoptosis and Autophagy by up-Regulating micro-RNA-27a. Artificial Cells, Nanomedicine, and Biotechnology, 47, 2940-2947. [Google Scholar] [CrossRef] [PubMed]
[25] 倪雅丽, 姚宇剑, 汤灿, 等. 缩泉益肾方与益智仁对糖尿病肾脏疾病小鼠疗效及肠道菌群的影响差异研究[J]. 海南医学院学报, 2021, 27(11): 820-826. [Google Scholar] [CrossRef
[26] 尹德辉, 朱叶, 吴珠, 等. 缩泉益肾方对糖尿病肾脏疾病患者的血清炎症因子及肾功能的影响[J]. 时珍国医国药, 2021, 32(8): 1931-1933.